Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Robert J. Michel, a director at Bio-Key International, acquired 2,971 shares of common stock on March 20, 2025, as payment for board meeting attendance fees.

Summary

• On March 20, 2025, Robert J. Michel, a director of Bio-Key International, acquired 2,971 shares of common stock.
• The shares were issued under the Issuer's 2023 Stock Incentive Plan as payment for board meeting attendance fees.
• Following the transaction, Michel directly owns 13,406 shares of Bio-Key International.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction of a director receiving stock compensation. It doesn't indicate any significant positive or negative news about the company.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

Directors receiving stock in lieu of cash compensation is a common practice, especially for smaller companies, to conserve cash and align director interests with shareholder value.

Comparison to Industry Standards

• Stock-based compensation for board members is a common practice across various industries, particularly in technology and growth-oriented companies.
• The amount of stock awarded can vary significantly based on company size, board responsibilities, and overall compensation strategy.
• Comparing Bio-Key's director compensation structure to similar companies in the cybersecurity or biometric authentication space would provide a more detailed benchmark.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Bio-Key International, BKYI, Robert J. Michel, Director, Stock Incentive Plan, Board Fees, Share Acquisition, Form 4